ALX Oncology Newsroom

Jefferies Downgrades ALX Oncology(ALXO.US) to Hold Rating, Cuts Target Price to $2

Moomoo NewsDec 20 12:32 ET

Jefferies Downgrades ALX Oncology Holdings to Hold, Lowers Price Target to $2

BenzingaDec 19 07:09 ET

Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Maintains Target Price $3

Moomoo NewsDec 19 05:34 ET

ALX Oncology Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow JonesDec 18 06:44 ET

Promising Evorpacept Data Bolsters Buy Rating for ALX Oncology Holdings

TipRanksDec 18 06:28 ET

LifeSci Capital Maintains ALX Oncology(ALXO.US) With Hold Rating

Moomoo NewsDec 17 16:31 ET

LifeSci Capital Maintains ALX Oncology(ALXO.US) With Hold Rating

Moomoo NewsNov 11 07:34 ET

Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Maintains Target Price $3

Moomoo NewsNov 8 10:31 ET

Stifel Nicolaus Sticks to Its Hold Rating for ALX Oncology Holdings (ALXO)

TipRanksNov 8 09:41 ET

Positive Outlook for ALX Oncology: Buy Rating Backed by Promising Clinical Data and Strong Financials

TipRanksNov 8 06:37 ET

ALX Oncology Holdings Analyst Ratings

BenzingaAug 16 10:29 ET

H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsAug 13 06:31 ET

Maintaining Buy Rating on ALX Oncology: Promising Clinical Data and Anticipated Progress of Evorpacept

TipRanksAug 13 06:27 ET

ALX Oncology Holdings Analyst Ratings

BenzingaAug 12 08:37 ET

ALX Oncology Holdings Analyst Ratings

BenzingaAug 9 08:26 ET

ALX Oncology Holdings Analyst Ratings

BenzingaAug 1 09:06 ET

Stifel Maintains ALX Oncology(ALXO.US) With Hold Rating, Cuts Target Price to $5

Moomoo NewsAug 1 08:31 ET

Stifel Nicolaus Remains a Hold on ALX Oncology Holdings (ALXO)

TipRanksAug 1 08:24 ET

H.C. Wainwright Maintains ALX Oncology(ALXO.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsAug 1 06:31 ET

Promising Future for ALX Oncology's Evorpacept: A Buy Rating Justified by Clinical Trials and FDA Prospects

TipRanksAug 1 06:24 ET